Jazz Pharma's decision to revoke U.S. patent for rival narcolepsy drug

Published Date: 02 Mar 2023

A U.S. court on Friday ordered Jazz Pharmaceuticals to revoke its patents related to its flagship narcolepsy drug Xyrem from the FDA-approved brand name drug after winning a case against Avadel foe CNS Pharmaceuticals.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Combination of significant weight gain and late motherhood greatly increases risk of breast cancer, study finds

2.

After two years, a significant left nasal obstruction was finally diagnosed.

3.

Heavy Cannabis Use Tied to Increased Head and Neck Cancer Risk

4.

CAR-T cell therapy for cancer causes 'brain fog,' study shows

5.

Making informed decisions and managing regret after prostate cancer treatment


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot